Live Breaking News & Updates on Clinical Global Impressions

Stay updated with breaking news from Clinical global impressions. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Phase 2b Study Explores Efficacy of MM-120 for the Treatment of GAD

Experts shared the study results in a poster presentation at the 2024 ASCP Annual Meeting. ....

United-states , American , Sarah-karas , American-society-of-clinical-psychopharmacology-annual-meeting , American-society-of-clinical-psychopharmacology , Clinical-psychopharmacology , Hamilton-anxiety-rating-scale , Clinical-global-impressions , Breakthrough-designation , Psychiatric-times , Psychiatric-times-june , Clinical-psychopharmacology-annual

Investigation Reveals Alarming ECT Practices in England

Audit of ECT usage, demographics, and adherence to guidelines and legislation raises concern over its continued use ....

Sweden , Australia , Norway , Belgium , John-read , Department-of-health , Mental-health , National-institute-of-care , National-health-service , National-institute , Health-act , Health-service

Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia

Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-'749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

France , United-states , Christophe-douat , Medincell-euronext , Christoph-correll , Eric-hughes , Teva-pharmaceuticals , Teva-pharmaceutical-industries-ltd , Euronext , Zucker-school-of-medicine , Medincell-announce-positive-phase , Once-monthly-subcutaneous-long-acting-injectable

Phase 3 SOLARIS Trial Demonstrates Potential of TEV-'749 in Schizophrenia

Phase 3 SOLARIS Trial Demonstrates Potential of TEV-'749 in Schizophrenia
psychiatrictimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from psychiatrictimes.com Daily Mail and Mail on Sunday newspapers.

Christophe-douat , Christoph-correll , Eric-hughes , Zucker-school-of-medicine , Drug-administration , Teva-pharmaceuticals , Negative-syndrome-scale , Clinical-global-impressions , Social-performance-scale , Zucker-school ,

Why Is Teva Pharmaceutical Stock Trading Higher On Wednesday? - Teva Pharmaceutical Indus (NYSE:TEVA)

Why Is Teva Pharmaceutical Stock Trading Higher On Wednesday? - Teva Pharmaceutical Indus (NYSE:TEVA)
benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.

Teva-pharmaceutical , Teva-pharmaceutical-industries-ltd , Negative-syndrome-scale , Clinical-global-impressions , Social-performance-scale , International-markets ,